Exploration of the activation mechanism of the epigenetic regulator MLL3 : a QM/MM study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Biomolecules 11 (2021), No. 1051
- Klassifikation
-
Biowissenschaften, Biologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Stuttgart
- (wer)
-
Universitätsbibliothek der Universität Stuttgart
- (wann)
-
2021
- Urheber
-
Miranda-Rojas, Sebastián
Blanco-Esperguez, Kevin
Tuñón, Iñaki
Kästner, Johannes
Mendizábal, Fernando
- DOI
-
10.18419/opus-13226
- URN
-
urn:nbn:de:bsz:93-opus-ds-132453
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Miranda-Rojas, Sebastián
- Blanco-Esperguez, Kevin
- Tuñón, Iñaki
- Kästner, Johannes
- Mendizábal, Fernando
- Universitätsbibliothek der Universität Stuttgart
Entstanden
- 2021
Ähnliche Objekte (12)
The epigenetic regulator Cfp1
The role of NFE2L2 mutations and the epigenetic regulator UHRF1 in hepatoblastoma
Synthesis of Epigenetic Regulator I-BET762 (GSK525762)
The hematopoietic master regulator RUNX1 reshapes the epigenetic landscape at the onset of hematopoiesis
Epigenetic regulation of PLS3 by the macrosatellite DXZ4 and the transcriptional regulator CHD4
Epigenetic modification of m6A regulator proteins in cancer
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
JMJD3: a critical epigenetic regulator in stem cell fate
MALAT1: An Epigenetic Regulator of Inflammation in Diabetic Retinopathy
The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness
The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness
Nano‐Regulator Inhibits Tumor Immune Escape via the “Two‐Way Regulation” Epigenetic Therapy Strategy
The epigenetic regulator Cfp1
The role of NFE2L2 mutations and the epigenetic regulator UHRF1 in hepatoblastoma
Synthesis of Epigenetic Regulator I-BET762 (GSK525762)
The hematopoietic master regulator RUNX1 reshapes the epigenetic landscape at the onset of hematopoiesis
Epigenetic regulation of PLS3 by the macrosatellite DXZ4 and the transcriptional regulator CHD4
Epigenetic modification of m6A regulator proteins in cancer
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
JMJD3: a critical epigenetic regulator in stem cell fate
MALAT1: An Epigenetic Regulator of Inflammation in Diabetic Retinopathy
The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness
The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness
Nano‐Regulator Inhibits Tumor Immune Escape via the “Two‐Way Regulation” Epigenetic Therapy Strategy
The epigenetic regulator Cfp1
The role of NFE2L2 mutations and the epigenetic regulator UHRF1 in hepatoblastoma
Synthesis of Epigenetic Regulator I-BET762 (GSK525762)
The hematopoietic master regulator RUNX1 reshapes the epigenetic landscape at the onset of hematopoiesis
Epigenetic regulation of PLS3 by the macrosatellite DXZ4 and the transcriptional regulator CHD4
Epigenetic modification of m6A regulator proteins in cancer
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
JMJD3: a critical epigenetic regulator in stem cell fate
MALAT1: An Epigenetic Regulator of Inflammation in Diabetic Retinopathy
The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness
The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness